Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial
- Resource Type
- ACADEMIC JOURNAL
- Source
- In eBioMedicine January 2022 75
- Subject
- Language
- English
- ISSN
- 2352-3964
- E-ISSN
- DOI
- 10.1016/j.ebiom.2021.103789